Touyz Rhian M, Chen Xin, Tabet Fatiha, Yao Guoying, He Gang, Quinn Mark T, Pagano Patrick J, Schiffrin Ernesto L
Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Montreal, Canada.
Circ Res. 2002 Jun 14;90(11):1205-13. doi: 10.1161/01.res.0000020404.01971.2f.
A major source of vascular smooth muscle cell (VSMC) superoxide is NAD(P)H oxidase. However, the molecular characteristics and regulation of this enzyme are unclear. We investigated whether VSMCs from human resistance arteries (HVSMCs) possess a functionally active, angiotensin II (Ang II)-regulated NAD(P)H oxidase that contains neutrophil oxidase subunits, including p22phox, gp91phox, p40phox, p47phox, and p67phox. mRNA expression of gp91phox homologues, nox1 and nox4, was also assessed in HVSMCs, human aortic smooth muscle cells, and rat VSMCs. HVSMCs were obtained from resistance arteries from gluteal biopsies of healthy subjects. gp91phox and nox4, but not nox1, were detected in HVSMCs. Nox1 and nox4, but not gp91phox, were expressed in human aortic smooth muscle cells and rat VSMCs. All NAD(P)H oxidase subunits were present in HVSMCs as detected by reverse transcriptase-polymerase chain reaction and immunoblotting. Ang II increased NAD(P)H oxidase subunit abundance. These effects were inhibited by cycloheximide. Acute Ang II stimulation (10 to 15 minutes) increased p47phox serine phosphorylation and induced p47phox and p67phox translocation. This was associated with NAD(P)H oxidase activation. In cells transfected with gp91phox antisense oligonucleotides, Ang II-mediated actions were abrogated. NADPH-induced superoxide generation was reduced by gp91ds-tat and apocynin, inhibitors of p47phox-gp91phox interactions. Our results suggest that HVSMCs possess a functionally active gp91phox-containing neutrophil-like NAD(P)H oxidase. Ang II regulates the enzyme by inducing phosphorylation of p47phox, translocation of cytosolic subunits, and de novo protein synthesis. These novel findings provide insight into the molecular regulation of NAD(P)H oxidase by Ang II in HVSMCs. Furthermore, we identify differences in gp91phox homologue expression in VSMCs from rats and human small and large arteries.
血管平滑肌细胞(VSMC)中超氧化物的一个主要来源是NAD(P)H氧化酶。然而,这种酶的分子特征和调控机制尚不清楚。我们研究了来自人类阻力动脉的血管平滑肌细胞(HVSMC)是否拥有一种功能活跃、受血管紧张素II(Ang II)调控的NAD(P)H氧化酶,该酶包含中性粒细胞氧化酶亚基,包括p22phox、gp91phox、p40phox、p47phox和p67phox。还评估了HVSMC、人主动脉平滑肌细胞和大鼠血管平滑肌细胞中gp91phox同源物nox1和nox4的mRNA表达。HVSMC取自健康受试者臀肌活检的阻力动脉。在HVSMC中检测到gp91phox和nox4,但未检测到nox1。在人主动脉平滑肌细胞和大鼠血管平滑肌细胞中表达了nox1和nox4,但未表达gp91phox。通过逆转录聚合酶链反应和免疫印迹检测到HVSMC中存在所有NAD(P)H氧化酶亚基。Ang II增加了NAD(P)H氧化酶亚基的丰度。这些作用被放线菌酮抑制。急性Ang II刺激(10至15分钟)增加了p47phox丝氨酸磷酸化,并诱导了p47phox和p67phox易位。这与NAD(P)H氧化酶激活有关。在用gp91phox反义寡核苷酸转染的细胞中,Ang II介导的作用被消除。NADPH诱导的超氧化物生成被gp91ds-tat和夹竹桃麻素(p47phox-gp91phox相互作用的抑制剂)减少。我们的结果表明,HVSMC拥有一种功能活跃的含gp91phox的中性粒细胞样NAD(P)H氧化酶。Ang II通过诱导p47phox磷酸化、胞质亚基易位和从头合成蛋白质来调节该酶。这些新发现为Ang II对HVSMC中NAD(P)H氧化酶的分子调节提供了见解。此外,我们确定了大鼠和人类小动脉及大动脉的血管平滑肌细胞中gp91phox同源物表达的差异。